PATENT CLAIM ANALYSIS

Application Number: 15760374
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "063000"]

Abstract:
To obtain a novel therapeutic drug for a malignant tumor or fibrosis. Used is a compound represented by formula (1), a salt thereof, or a solvate thereof. Also used is a therapeutic drug for a malignant tumor or a therapeutic drug for fibrosis, comprising a compound represented by formula (1), a salt thereof, or a solvate thereof.

Claim (Index 11):
A method of treating a malignant tumor, comprising the step of:\n administering to a patient a compound, a salt thereof, or a solvate thereof, wherein the patient has already received 5-FU, the compound represented by formula (2): wherein R 7  and R 8  are the same or different and each represent optionally substituted C 1-6  alkyl or optionally substituted C 2-6  alkenyl, or administering to a patient 5-FU, wherein the patient has already received a compound, a salt thereof, or a solvate thereof, the compound represented by formula (2).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 2.46429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14871472', '14111757', '14092425', '15475108', '15434531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7637670707077577
- 35 USC 102 Novelty (BERT): 0.5121742141483981
- Combined Prediction Score: 0.7386077850518218
- Mean Citation Score: 264.80514000000005
- Max Citation Score: 266.23618
- Similarity Product: 166.59381573953155

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test